Statistics
Publications
24
Citations
4.7K
H-Index
22
Active since
1972
Robert Feldman is an author at Eli Lilly (United States) specializing in medicine, pharmacotherapy, and pharmacology.
Publications per year
1972–2023
24
24
Donanemab in Early Symptomatic Alzheimer Disease
John R. Sims, Jennifer A. Zimmer, Cynthia Evans et al. · JAMA · 2023 · 2.6K citations · Full text
Medicine, Neurology, Neuroscience +17
Robert Feldman, Rainard Fuhr, Igor Smolenov et al. · Vaccine · 2019 · 463 citations · Full text
Dan H. Barouch, Frank Tomaka, Frank Wegmann et al. · The Lancet · 2018 · 342 citations
1–5 of 24